The latest price target for Arcosa (NYSE:ACA) was reported by Barclays on October 29, 2024. The analyst firm set a price target for $106.00 expecting ACA to rise to within 12 months (a possible 6.69% upside). 7 analyst firms have reported ratings in the last year.

The latest analyst rating for Arcosa (NYSE:ACA) was provided by Barclays, and Arcosa initiated their overweight rating.

The last upgrade for Arcosa Inc happened on August 7, 2024 when Stephens & Co. raised their price target to $96. Stephens & Co. previously had an equal-weight for Arcosa Inc.

The last downgrade for Arcosa Inc happened on November 8, 2022 when Stephens & Co. changed their price target from $75 to $65 for Arcosa Inc.

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Arcosa, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Arcosa was filed on October 29, 2024 so you should expect the next rating to be made available sometime around October 29, 2025.

While ratings are subjective and will change, the latest Arcosa (ACA) rating was a initiated with a price target of $0.00 to $106.00. The current price Arcosa (ACA) is trading at is $99.35, which is within the analyst’s predicted range.